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Abstract
The goal of our study is to develop and characterize mucoadhesive films with entrapped lysozyme 
based on gelatin/sodium carboxymethyl cellulose as perspective antimicrobial preparation. 
Lysozyme in mucoadhesive films retains more than 95 % of its initial activity for 3 years of 
storage. Different physical-chemical and biochemical characteristics of entrapped enzyme were 
evaluated, such as film thickness, weight, time of dissolution in water, bioadhesive force, in vitro 
lysozyme release, pH- and thermoprofiles of hydrolytic activity, effect of γ-sterilization, etc. We 
have shown that gelatin/sodium carboxymethyl cellulose films have adhesive force on the level of 
4380 Pa. Scanning electron microscopy images shows the relative uniformity of the gelatin surface 
with entrapped lysozyme. Mucoadhesive films with lysozyme have 100% bactericidal effect on the 
test strain, Staphylococcus aureus ATCC 25923 F - 49 and thus could be considered as a 
perspective antimicrobial preparation.
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1. Introduction
Lysozyme (muramidase, EC.3.2.1.17) catalyzes the hydrolysis of the cell walls of Gram-
positive bacteria and results in a non-specific innate-immunity response against the invasion 
of bacterial pathogens (Jollès & Jollès, 1984). Additionally, some researchers reported that 
this enzyme is a unique enzybiotic that exerts not only antibacterial, but also antiviral, anti-
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inflammatory, anticancer, and immunomodulatory activities (Bachali et al., 2002; Bu et al., 
2006; Ferrari, Callerio & Podio, 1959; Helal, Bader & Melzig, 2012; Karle, Hansen & 
Killmann, 1974; Kawamura et al., 1988; Morioka, Nishimura & Matsumura, 1970; 
Ogundele, 1998; Okada, 1977; Rymuszka A., 2000).
Reduction of lysozyme in the oral cavity contributes to the accelerated growth of 
conditionally pathogenic or pathogenic microorganisms (Iacono, MacKay, DiRienzo & 
Pollock, 1980). This and other factors are causes of the development of dental diseases 
(stomatitis, gingivitis and periodontitis), which affect ~70% of the human population. Thus, 
the reduction of lysozyme in the oral cavity constitutes a major health and social problem. 
(Petkar, 2014).
The oral cavity has been proposed as a potential topical delivery site for proteins in the 
treatment of dental diseases. Delivery at this site, however, is challenging due to the special 
structure of the mucin layer, salivation and muscle activity of the mouth (Sankar et al., 2011; 
Smart, 1993). Furthermore, therapeutic agents must overcome the permeability barrier, 
evade protecting biological drugs, such as peptides and proteins from enzymatic 
degradation, have an acceptable taste to patients, and be easily administered without being 
easily swallowed by accident (Sudhakar, Kuotsu & Bandyopadhyay, 2006).
Creation and application of mucoadhesive polymeric systems (gels, films, microcapsules) 
with immobilized enzymes could help to overcome some of these challenges. Over the last 
few decades, there were many examples of the development of lysozyme-loaded forms with 
used polymeric matrix of natural or synthetic origin, such as siliceous mesocellular foams 
(Sridhar et al., 2014), ethylene vinyl alcohol copolymers (Muriel-Galet, Talbert, Hernandez-
Munoz, Gavara & Goddard, 2013), electrospun chitosan nanofiber (Park, Kim, Park, Jang, 
Min & Kim, 2013), glycerol diglycidyl ether cross-linked oxidized starch (Zhao et al., 
2015), carboxymethyl chitosan-poly(amidoamine) dendrimer (Zhang, Zhao, Wen, Zhu, Yang 
& Yao, 2013), cellulose and polyacrylamide (Datta, Armiger & Ollis, 1973), calcium 
carbonate/carboxymethyl cellulose (Lu, Zhang, Ma, Song & Gu, 2012), keratin sponge 
(Kurimoto, Tanabe, Tachibana & Yamauchi, 2003), chitosan (Bucatariu, 2013), silica 
nanotubes and nanotubes (Ding, Shao, Liu, Xiao & Chen, 2005; Xiao, Tao, Zou & Chen, 
2008), zeolite (Chang, Huang, Lin, Chiu & Tsai, 2006), polystyrene (Wu & Daeschel, 2007), 
and others. We also consider this direction as promising and thus aimed the current study to 
develop and characterize mucoadhesive films with incorporated lysozyme based on gelatin/
sodium carboxymethyl cellulose as perspective antimicrobial preparation.
The proposed system based on gelatin/CMC in comparison with the other polymeric 
systems with included lysozyme that have already been reported in the literature (Bucatariu, 
2013; Kurimoto, Tanabe, Tachibana & Yamauchi, 2003) has the following advantages: 1) 
better biocompatibility; 2) higher permeability; 3) increased hydrophilic character; 4) faster 
biodegradability; 5) absence of toxicity; 6) suitable form and size of the film; 7) higher 
mucoadhesive properties; and 8) low cost.
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2. Material and Methods
2.1. Materials
Lysozyme (activity 40000 U/mg, M.m. ≈ 14.4 kDa) and Micrococcus lysodeikticus ATCC 
№4698 were purchased from Sigma. Sodium carboxymethyl cellulose (Na-CMC) was 
obtained from FMC Biopolymer. Gelatin type B and the other chemicals, used in this work, 
were of analytical grade from local sources.
2.2. Assay of lysozyme hydrolytic activity
The lysozyme activity was measured using the turbidimetric assay based on following the 
method described (Gorin, Wang & Papapavlou, 1971) and preparation data sheet. One unit 
will produce a change in A450 of 0.001 per minute at pH 6.24 at 25 °C, using a suspension 
of Micrococcus lysodeikticus as substrate, in a 2.6 ml reaction mixture (1 cm light path). 
Suspension of Micrococcus lysodeikticus and lysozyme solution were prepared in 0.1 M 
sodium phosphate buffer (pH 6.2).
Lytic activity was calculated as follows:
where ΔA450 – the decrease in optical density for 1 min.
F – dilution factor.
C – protein concentration.
0.001– decrease in optical density, which corresponds to 1 unit of activity.
Self-sedimentation of cells was measured and considered as a control value.
2.3. Preparation of gelatin/Na-CMC mucoadhesive films with lysozyme
Known amounts of gelatin solution and Na-CMC were dissolved separately in water. The 
gelatin solution and Na-CMC solution were mixed, giving two final polymeric 
concentrations 15.0 % w/v and 0.75 % w/v, respectively.
The lysozyme-loaded gelatin/Na-CMC films were prepared by mixing 5 ml of 4 % 
lysozyme solution, 1 ml glycerol and 9 ml gelatin/Na-CMC solution. The obtained solution 
was poured into a petri dish (9 cm in diameter) and dried at 25 °C for 48 h. Then, circles of 
0,64 cm2 were cut from each film. Films were packed and then irradiated at incremental 
doses (10, 17, 28 kGy) of gamma radiation emitted by a 60Coradiation source. Then the 
films stored at not more than 50% of relative humidity and 4°C.
2.4. Characterization of mucoadhesive films
Thickness, weight, time of dissolution in water, and flatness of mucoadhesive films were 
characterized using a Mututoyo pocket thickness gauge (Mututoyo Mtc. Co. Ltd., Tokyo, 
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Japan), electronic balance, and stopwatch, respectively. Random sampling of films was done 
from each batch, and different evaluations were performed in triplicate (n = 5).
2.5. Determination of extracted lysozyme percentage
An accurately weighed 50 mg of lysozyme-loaded films were crushed and dissolved in 250 
ml in water by stirring for 3 h using magnetic stirrer. The resulting solutions were then 
centrifuged using Heraeus Labofuge 400 R.
The suitably diluted filtrate was assayed using a UV-visible spectrophotometer (Shimadzu/
UV-1700, Japan) at 280 nm. The percentage of extracted lysozyme was calculated using the 
formula:
2.6. Determination of mucoadhesive properties of films
Mucoadhesive properties of films were determined by one of the methods (Woertz, Preis, 
Breitkreutz & Kleinebudde, 2013) on a TA.XT2 Texture analyzer instrument. The polymeric 
film was fixed on the mobile rod of device and brought in contact with wetted mucosal 
tissue. The load on rod (2 MPa) and the retention time (60 s) were fixed. Next, at an angle of 
90°, the breaking off the rod of device with sample of polymeric film fixed on it, from the 
mucosal tissue, was accomplished. The device automatically determines force of adhesion. 
The experiment was conducted at room temperature (23 °C) with five trials.
As a model of mucosal tissue surface, a porcine small intestine segment was used. For the 
experiment, samples with area of 5 sm2, morphologically homogeneous and without obvious 
physical defects were excised.
2.7. Surface morphology studies
Selected samples of mucoadhesive films containing the lysozyme were investigated for 
surface morphology by scanning electron microscopy. SEM samples were sputter coated 
with Au/Pd using an Edwards Auto 306 (Milan, Italy) electron-beam evaporator and was 
examined using a scanning electron microscope (Zeiss EVO 50XVP) at 10 kV accelerating 
voltage.
2.8. In vitro release study
The in vitro release profile of lysozyme from the mucoadhesive films was determined at 
37 °C using a shaking water bath. A fixed mass of lysozyme-loaded film was suspended in 3 
ml of distilled water. Then nine samples were put in a shaking water bath for 180 min with 
constant temperature of 37 °C. Film is not removed from the solution before measuring 
lysozyme activity. It is dissolving gradually and releasing enzyme. As a control we used the 
film without lysozyme (placebo). We used minimal water volume for modelling conditions 
similar to human organism. Hydrolytic activity of lysozyme was determined at 5, 15, 30, 45, 
60, 75, 90, 120, and 180 min according to item 2.2.
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2.9. Effect of pH and temperature on the activity of free and released lysozyme
The effect of pH on free and released from films lysozyme was studied by assessing the 
activity of preparations at different pH values (3.0–10.0) using the following buffers: citric-
phosphate acetate (3.0–6.0), sodium phosphate (pH 7.0–8.0), glycine-sodium hydroxide 
(9.0–10.0). Lysis reaction has been conducted at 25°C in the buffer solutions mentioned 
above for pH-profile obtaining. Previously enzyme has been released from the film by 
dissolving it at 37°C. The film without lysozyme (placebo) was used as a control.
The effect of temperature on free and released from films lysozyme was determined by 
changing the reaction medium temperature in the range from 20 to 80 °C according to item 
2.2.
2.10. Thermostability of free and released lysozyme
The thermostability of the free and released from mucoadhesive films lysozyme was 
determined by measuring the residual enzymatic activity at 80 °C in 0.1 M sodium 
phosphate buffer (pH 6.2) for 300 min. After a 30 min time interval, samples were taken and 
assayed for their enzymatic activity. Each set of experiments was carried out in triplicate. 
The thermal inactivation constants were calculated from the slope of logarithmic value of 
residual activity vs. time plot by the linear regression method.
2.11. pH-stability of free and released lysozyme
The pH-stability of the free and released from mucoadhesive films lysozyme was determined 
by measuring the residual enzymatic activity at pH 5.5 in 0.1 M sodium phosphate buffer for 
120 min. Lysis reaction has been conducted at 25°C in the above buffer solution. Previously 
enzyme has been released from the film by dissolving it at 37°C. As a control we used the 
film without lysozyme (placebo). After 15min, samples were taken and assayed for 
enzymatic activity. Each set of experiments was carried out in triplicate.
2.12. Storage stability
Storage stability of free and enzyme in the films was investigated by determining the 
residual activity after storing the enzyme at intervals of up to 3 years. Samples (1.0 g of 
lysozyme films) were stored at 4 °C. Activity assay of released lysozyme was performed at 
14 days, and then 30 days, intervals.
2.13. Antimicrobial effect of lysozyme films
The antimicrobial activity of the lysozyme film was examined against Staphylococcus 
aureus ATCC 25923 F-49, Pseudomonas aeruginosa 415, Escherichia coli 055 K59912/4, 
and Candida albicans ATCC 885 – 653 according to the inhibition zone assay (Lian, Ma, 
Wei & Liu, 2012). Fifteen milliliters of molten nutrient agar were inoculated with a 100 μl of 
bacterial culture (colony count of 107 cfu/ml). One sterile film disk (0.64 sm2) with 
lysozyme was placed at the center of the bacterial lawn. The agar plates were then incubated 
at 37 °C for one week in an appropriate incubation chamber. All experiments were carried 
out under sterile conditions. The diameter of the inhibition zone (mm), surrounding the test 
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sample, was measured each day and was used as an indicator of antimicrobial effectiveness 
of the lysozyme-loaded film. The experiment was carried out in triplicate.
3. Results and discussion
3.1. Lysozyme inclusion
Gelatin and sodium carboxymethyl cellulose, the mucoadhesive polymers for medical 
purposes, were selected as carriers for lysozyme. These polymers are characterized by high 
hydrophilicity, and the large number of available functional groups capable of forming ionic 
or hydrogen bonds with biologically active substances. (Laffleur, 2014; Veis, 1964). Because 
of these properties, gelatin and sodium carboxymethyl cellulose are promising for non-
covalent immobilization, with a lesser degree of affecting the structure of the enzyme protein 
globule.
Previously (Dekina, Romanovska & Gromovoy, 2011), we had investigated the behavior of 
lysozyme molecules inclusion in solutions of gelatin and sodium carboxymethyl cellulose by 
matrix assisted laser desorption/ionization (MALDI). The results confirmed the presence of 
lysozyme in an aqueous solution in the monomeric and oligomeric forms. It was also shown 
for the first time that the lysozyme inclusion by non-covalent interactions in the gelatin 
solution and Na- CMC leads to the dissociation of the oligomeric structure of the enzyme.
Preliminary experiments on animals showed high bioavailability and therapeutic efficacy in 
the treatment of artificially induced stomatitis on rats during buccal administration of 
lysozyme. To adapt the lysozyme concentration in our films to humans, we used the 
conversion factors of animal doses to human equivalent doses (HED) based on body surface 
area for extrapolating doses between species according to the FDA “Guidance for Industry: 
Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in 
Adult Healthy Volunteers” (FDA, 2005).
HED was calculated as follows:
Lysozyme entrapment efficiency in all films is listed in Table 1. As one could see from there, 
the best results were observed in the samples 4 and 5 at a weight ratio lysozyme: gelatin 1: 
3.5 and 1: 5, respectively.
3.2. Properties of mucoadhesive films with lysozyme
The main characteristics of mucoadhesive films obtained as a result of enzyme inclusion into 
polymeric matrix based on gelatin with addition of Na-CMC are shown in Table 2.
As clearly shown from Table 2, the mechanical stability of the films was good. This is 
important for buccal delivery system. Time of the film dissolution in water and physiological 
solution is similar, 17.5 and 18.5 min at 37 °C, respectively.
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After sterilization by γ-radiation at the doses of 10, 17, 28 kGy the included enzyme retains 
100 % of its biological activity (Table 2). This indicates the existence of radio protective 
properties of gelatin for lysozyme. The impact of high energetic rays between 10 and 100 
kGy on gels and solutions of gelatin was studied earlier (Voigt, 1986). It was shown that 
physical and biopharmaceutical properties of gelatin depend on the content of glycerol and 
water. We suggest that the low water content in the films causes radioprotective properties of 
gelatin for the lysozyme.
Mucoadhesive force of gelatin/Na-CMC combination in films is 4380±250 Pa (Table 2), 
which is comparable to the values of adhesion for the most commonly used adhesive 
polymers. Various mechanisms of mucoadhesion were considered in the recent reviews of 
the mucoadhesive forms (Carvalho, Bruschi, Evangelista & Gremião, 2010; Khurana, 
Madhav & TANGRI, 2011). These mechanisms include electronic, adsorption, wetting, 
diffusion, and fracture theories. But the chemical and physical basis of mucoadhesion is not 
well understood yet, and adhesion of gelatin/Na-CMC films can be explained by several 
theories.
Results of SEM show some irregularity of the gelatin/Na-CMC surface with entrapped 
lysozyme (Fig. 1b). As can be seen from the selected photographs, polymeric system 
contains enzyme agglomerates of various size but not greater than 3 microns in diameter (if 
we accept that the particles are spherical).
Fig. 2 shows the ratio of elements on the surface of mucoadhesive films with and without 
lysozyme detected by SEM. Carbon, oxygen, and nitrogen are the most common elements 
on the surface of mucoadhesive films both with and without lysozyme; their accumulated 
ratio 96.05% and 98.06% respectively. Location of lysozyme on the surface and in the layer 
of polymeric film provides a gradual release of the enzyme, which is confirmed by further 
research.
3.3. Lysozyme release
The amount of lysozyme released from the film matrix is illustrated in Fig. 3. When 
lysozyme-containing composite films were placed in the Na-phosphate buffer solution or 
distilled water, the films were swollen as a result of the diffusion of water molecules into the 
polymeric film structure, leading to the release of incorporated lysozyme into aqueous 
environment from polymeric matrix. The rate of lysozyme release and its completeness 
showed that the 75 % of the enzymatic activity of included lysozyme is reached after 30 min 
of incubation. Maximum hydrolytic activity is reached after 90 min of incubation and 
maintained at a high level for 3 hours.
3.4. Effect pH and temperature
The effect of pH on the activity of the free and released lysozyme was determined in the pH 
range from 3.0 to 10.0 at 37°C. As shown in Fig. 4, the optimum pH of the free and released 
lysozyme is the same (5.5 – 6.5 unites). However, the released enzyme was characterized by 
extended pH-profile of hydrolytic activity in the acidic (by 0.5 units.) and alkaline (1.0 unit) 
regions. Released enzyme has more gradual decline in activity at acidic values of pH (Fig. 3) 
due to the stabilizing effect of the matrix.
Dekina et al. Page 7
Carbohydr Polym. Author manuscript; available in PMC 2017 May 31.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Charge state of lysozyme and its activity can be changed depending on the pH of the 
solution. The polymeric matrix modifies the microenvironment of the enzyme, thus 
preventing it from sudden fluctuations in pH and lysozyme is active over a wide pH range.
The effect of temperature on the activity of free and released lysozyme was investigated in 
the temperature range from 20°C to 80°C at pH 6.2. The relative activity expressed in 
percentage of the maximum activity is presented in Fig. 5 as a function of temperature. As 
shown in Fig. 5, the maximum of activity for both free and released lysozyme is obtained at 
55°C. However, the activity of the released enzyme in the temperature range of 60–80 °C is 
lower for 10–20 % than that of free lysozyme, which is possible due to the influence of 
partial denaturation changes of gelatin matrix.
The Fig. 6 shows the effect of heating time on the activity of free and released lysozyme. 
Study of the thermal stability of free and released lysozyme demonstrates a 1.7-fold 
decrease in the constants of thermal inactivation of released enzyme at 80°C, so for free 
lysozyme Kin is of 9.2·10−3 min−1, for released - 5.3·10−3 min−1. Decrease in thermal 
stability at 80°C is also associated with changes in denaturation gelatin matrix.
3.4. pH-stability of free and released lysozyme
An inflammation area is characterized by a pH around 5.5 (Reis, 2002). Therefore, it is 
important for developed preparation to be stable at weakly acidic pH environment. The 
activity of both released and free lysozyme significantly decreased with the lapse of time, 
but activity of the released enzyme decreases more smoothly. Thus, after incubation of 30 
minutes, lysozyme from mucoadhesive film is 24% more active than the free enzyme (Fig. 
7). We suggest that the lysozyme is stabilized by polymers in the buffer solution due to 
interactions with them.
3.5. Storage stability
Stability of lysozyme-loaded films was studied during a period of 3 years. We compared the 
lysozyme stability in a buffer solution because in this form the enzyme has been used in 
clinical practice. The films were stored with the temperature of 4°C. The free enzyme lost 
hydrolytic activity within 14–17 days in buffer solution, but enzyme from mucoadhesive 
film was highly stable – residual hydrolytic activity after 36 month of storage is 95–100 % 
(Fig. 8).
3.5. Antimicrobial action of lysozyme-loaded mucoadhesive films
Results of the antimicrobial experiments had shown that mucoadhesive polymeric films with 
lysozyme influenced the growth of all test strains studied after 24 h incubation at 37 °C 
(Table 3). Maximal bacteriostatic action was noted for Staphylococcus aureus (diameter of 
the growth inhibition zone = 1.7 cm). Activity against three other strains was somewhat 
smaller but still high (diameter of the growth inhibition zone = 1.1–1.3 cm). The obtained 
results indicate that lysozyme diffuses into the agar gel from the polymeric films and inhibits 
microbial growth.
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In addition, we have also shown, that inclusion of lysozyme in gelatin/CMC allows 
obtaining a preparation with full entrapment of protein and 100% retention of activity after 
release. Mucoadhesive films with lysozyme could be stored for 3 years at 4° C without loss 
of enzyme activity. This medical form of entrapped lysozyme can be can be a prospective 
treatment also for certain ulcers, measles, some skin diseases, and post operation infections 
as antibacterial agent.
4. Conclusion
The results of our study indicate a possibility to prepare highly stable mucoadhesive form of 
lysozyme (residual hydrolytic activity after 36-month storage is 95–100%). The enzyme was 
incorporated into gelatin/sodium carboxymethyl cellulose films. The experimental results 
showed good mucoadhesive properties of films and retention of physicochemical properties 
of the enzyme after release from the film. The film with lysozyme was effective in inhibiting 
the growth of Staphylococcus aureus ATCC 25923 F – 49, Pseudomonas aeruginosa 415, 
Escherichia coli 055 K59912/4, Candida albicans ATCC 885 – 653.
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Fig. 1. 
Scanning electron micrographs of the surface of gelatin/Na-CMC film (a) and gelatin/Na-
CMC film with included lysozyme (b – 30 μm, b1, b2 – 2 μm).
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Fig. 2. 
Ratio of elements (%) on the surface of mucoadhesive films by SEM at n=9.
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Fig. 3. 
Release of lysozyme from mucoadhesive film at 37 °C and pH 6.2.
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Fig. 4. 
The effect of pH on the activity of free and released lysozyme at 25 °C.
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Fig. 5. 
The effect of temperature on the activity of free and released lysozyme at pH 6.2.
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Fig. 6. 
Thermal stability of free and released lysozyme at 80 °C and pH 6.2.
A/A0 – residual lysozyme activity.
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Fig. 7. 
Stability of free and released lysozyme at pH 5.5 and 37 °C.
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Fig. 8. 
Storage stability of free and lysozyme released from mucoadhesive film at 5 °C.
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Table 2
Characteristics of mucoadhesive films with lysozyme.
Property, units Value ±SD*
Hydrolytic activity of one film, unit 75480±1250
Lysozyme content in one film, mg 2.0
Area, cm2 0.8±0.1
Thickness, mm 0.35±0.02
Average weight of the film, mg 8±0.02
Visual characteristics of the film transparent, smooth, light yellow
Time of film dissolution in water, physiological saline, min at 37 °C 18±0.5
Water content in film, % 10.0±1.7
Activity after sterilization by γ-irradiation (10–28 kGy) 100 %
Mucoadhesive force, Pa 4380±250
*SD, mean-square deviation, n = 3.
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Table 3
Antimicrobial effect of mucoadhesive films
Test-strain of the microorganism
Diameter of the growth inhibition zone, cm, ±SD*
Film with lysozyme Control film (sample without lysozyme)
Staphylococcus aureus ATCC 25923 F-49 1.7 ± 0.15
0.0
Pseudomonas aeruginosa 415 1.1 ± 0.10
Escherichia coli 055 K59912/4 1.2 ± 0.13
Candida albicans ATCC 885 – 653 1.3 ± 0.13
*SD, mean-square deviation, Р<0.05, n=3
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